Table 1 Clinical assessment of BAD-related stroke
Items | Assessment |
|---|---|
Demographics | Age, gender |
Medications prior to stroke | Antiplatelet drugs, statins, anticoagulant drugs, and tirofiban |
Medical history | Stroke, hypertension, diabetes mellitus, dyslipidemia, heart disease, chronic respiratory disease, autoimmune diseases, blood system disorders, and thyroid disorder |
Personal history | Smoking, alcohol use, and daily activity |
Family history | Cardiovascular and cerebrovascular diseases |
Current stroke onset | |
Time information | Time of symptom onset, arrival at hospital, and enrollment |
Stroke symptom | Types (ischemic stroke or transient ischemic attack [TIA]), and presentation (pure motor hemiparesis, pure sensory, sensorimotor syndrome, and others) |
Blood pressure | (1) Arrival at hospital, enrollment, and each follow up; (2) Monitor of blood pressure within 72 h after enrollment (≥ 3 times per day, interval time ≥ 2 h) |
Heart rate | Arrival at hospital, enrollment, and each follow up |
Intake and output volume | Monitor of intake and output volume within 72Â h after enrollment |
Stroke severity | National Institutes of Health Stroke Scale |
Functional assessment | mRS |
Activities of daily living | Barthel index |
Reperfusion therapy | Data of intravenous thrombolysis, and change of NIHSS score |
Medications after stroke | Antiplatelet drugs, lipid-lowering drugs including statins, anticoagulant drugs, antihypertensive drugs, antidiabetics, and other neuroprotective drugs |
END | Therapies for END, and time of END occurrence |
Use of tirofiban | Time, dosage, duration and side effects |